Concepedia

Mauro Rogério de Barros Wanderley

MR

Statistics

Publications

3

Citations

528

H-Index

3

Active since

2018

Affiliations

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo(Current)

Universidade de São Paulo

Instituto do Câncer do Estado de São Paulo

Mauro Rogério de Barros Wanderley is an author at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo specializing in anthracycline cardiotoxicity, pharmacology, and chemotherapy.

ORCID

Publications per year

2018–2025

3

Publications

3

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

Mônica Samuel Ávila, Silvia Moreira Ayub‐Ferreira, Mauro Rogério de Barros Wanderley et al. · Journal of the American College of Cardiology · 2018 · 497 citations

, , +12

Carvedilol as Single Therapy for Heart Failure With Improved Ejection Fraction

Deborah de Sá Pereira Belfort, Edimar Alcides Bocchi, Caio Rebouças Fonseca Cafezeiro et al. · JACC Heart Failure · 2025 · 16 citations

, , +12

Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial

Mauro Rogério de Barros Wanderley, Mônica Samuel Ávila, Miguel Morita Fernandes-Silva et al. · Oncotarget · 2022 · 15 citations · Full text

, , +17

1–3 of 3